NeuPath Health

NeuPath Health Debt/Market Cap

The Debt to Market Capitalization Ratio of NeuPath Health (NPTH.V) as of Nov 12, 2026 is 23.62 %. In the previous year, Debt to Market Capitalization Ratio was 23.27 % — a change of 1.49% (higher).

Debt/Market Cap

23.62 %

YoY

1.49%

Last updated:

Debt to Market Capitalization Ratio of NeuPath Health is 2025 23.62 % . Debt to Market Capitalization Ratio of NeuPath Health was 2024 23.27 % . It decreases by 1.49% higher compared to the previous year.

The NeuPath Health Debt/Market Cap history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Debt/Market Cap
Date
Debt/Market Cap
Jan 1, 2019
23.14 CAD
Jan 1, 2020
21.00 CAD
Jan 1, 2021
21.21 CAD
Jan 1, 2022
15.70 CAD
Jan 1, 2023
23.27 CAD
Jan 1, 2025
23.62 CAD
The NeuPath Health Debt/Market Cap history
YEARDebt/Market CapYoY
23.62 %+1.49%
23.27 %+48.18%
15.70 %-25.94%
21.21 %+1.00%
21.00 %-9.26%
23.14 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

NeuPath Health Stock analysis

What does NeuPath Health do? NeuPath Health, Inc. generates revenue through chronic pain management services provided at its clinics in Ontario and Alberta, offering comprehensive assessments and rehabilitation for chronic pain, musculoskeletal/back injuries, sports injuries, and concussions. The company serves employers and disability insurers with workplace health services and independent medical assessments via a national network of healthcare providers. Additionally, NeuPath provides contract research services to pharmaceutical and biotechnology companies. Its healthcare providers include physiatrists, neurologists, anesthesiologists, general practitioners with specialized pain training, medication management physicians, athletic therapists, and nurses. The primary buyers of NeuPath's services are employers and disability insurers seeking workplace health solutions and independent medical evaluations. Pharmaceutical and biotechnology companies contract NeuPath for research services. The company's clinic services target patients with chronic pain conditions, while its research division serves the pharmaceutical industry. NeuPath's network spans Ontario and Alberta, with a focus on specialized medical expertise across multiple disciplines. NeuPath Health, Inc. operates a network of medical clinics delivering chronic pain management and rehabilitation services. Its national provider network supports workplace health and independent medical assessments for employers and disability insurers. The firm's contract research division works with pharmaceutical and biotechnology companies, leveraging its medical expertise in pain management and rehabilitation. The company's service mix combines direct patient care with specialized industry contracts, creating multiple revenue streams from healthcare providers and corporate clients. NeuPath Health is one of the most popular companies on Eulerpool.

Frequently Asked Questions about NeuPath Health stock

Debt to Market Capitalization Ratio of NeuPath Health is 23.62 % in 2025.

Debt to Market Capitalization Ratio of NeuPath Health changed from 23.27 % to 23.62 %, representing a 1.49% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Debt to Market Capitalization Ratio NeuPath Health since 2006 – with annual values, charts, and detailed analysis.

Debt/Market Cap compares total debt to the market value of equity. It provides a market-based view of financial leverage.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Debt to Market Capitalization Ratio's NeuPath Health with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — NeuPath Health

All Key Metrics — NeuPath Health